These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7649575)

  • 81. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Defining normal ambulatory blood pressure in relation to target organ damage and prognosis.
    Verdecchia P; Porcellati C
    Am J Hypertens; 1993 Jun; 6(6 Pt 2):207S-210S. PubMed ID: 8347320
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study.
    Khattar RS; Senior R; Lahiri A
    Circulation; 1998 Nov; 98(18):1892-7. PubMed ID: 9799210
    [TBL] [Abstract][Full Text] [Related]  

  • 84. "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.
    Julius S; Mejia A; Jones K; Krause L; Schork N; van de Ven C; Johnson E; Petrin J; Sekkarie MA; Kjeldsen SE
    Hypertension; 1990 Dec; 16(6):617-23. PubMed ID: 2246029
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Assessment of arterial compliance by carotid midwall strain-stress relation in hypertension.
    Bella JN; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB
    Hypertension; 1999 Mar; 33(3):793-9. PubMed ID: 10082489
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Isolated office hypertension and end-organ damage.
    Ferrara LA; Guida L; Pasanisi F; Celentano A; Palmieri V; Iannuzzi R; Gaeta I; Leccia G; Crivaro M
    J Hypertens; 1997 Sep; 15(9):979-85. PubMed ID: 9321745
    [TBL] [Abstract][Full Text] [Related]  

  • 87. White-coat hypertension in the elderly. Echocardiographic analysis. A substudy of the EPICARDIAN project.
    Puchades R; Ruiz-Nodar JM; Blanco F; Rodríguez F; Gabriel R; Suárez C
    Rev Esp Cardiol; 2010 Nov; 63(11):1377-81. PubMed ID: 21070734
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pre-clinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damage independent of blood pressure?
    Devereux RB; Okin PM; Roman MJ
    Ethn Dis; 1998; 8(2):138-48. PubMed ID: 9681280
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent?
    Karter Y; Curgunlu A; Altinişik S; Ertürk N; Vehid S; Mihmanli I; Ayan F; Kutlu A; Arat A; Oztürk E; Erdine S
    Blood Press; 2003; 12(5-6):307-13. PubMed ID: 14763662
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Noninvasive study of endothelial function in white coat hypertension.
    Gómez-Cerezo J; Ríos Blanco JJ; Suárez García I; Moreno Anaya P; García Raya P; Vázquez-Muñoz E; Barbado Hernández FJ
    Hypertension; 2002 Sep; 40(3):304-9. PubMed ID: 12215471
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Study by ultrasound high-resolution B-mode imaging.
    Ferrara LA; Mancini M; Celentano A; Galderisi M; Iannuzzi R; Marotta T; Gaeta I
    Arterioscler Thromb; 1994 Aug; 14(8):1290-6. PubMed ID: 8049190
    [TBL] [Abstract][Full Text] [Related]  

  • 92. White coat hypertension.
    Pickering TG
    Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):192-8. PubMed ID: 8744545
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Effect of "Unclassified" Blood Pressure Phenotypes on Left Ventricular Hypertrophy.
    Kasap Demir B; Başaran C; Demircan T; Erfidan G; Özdemir Şimşek Ö; Arslansoyu Çamlar S; Alaygut D; Mutlubaş F; Karadeniz C
    Turk Arch Pediatr; 2024 Jan; 59(1):43-48. PubMed ID: 38454259
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Ambulatory blood pressure in the elderly with hypertension].
    Kuwajima I
    Nihon Ronen Igakkai Zasshi; 1994 Dec; 31(12):921-6. PubMed ID: 7699938
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Structure and function of the carotid body in New Zealand genetically hypertensive rats.
    Bee D; Barer G; Wach R; Pallot D; Emery C; Jones S
    Q J Exp Physiol; 1989 Sep; 74(5):691-701. PubMed ID: 2531903
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Characteristics of cardiovascular morphology and function in the high-normal subset of hypertension defined by JNC-VI recommendations.
    Kimura Y; Tomiyama H; Nishikawa E; Watanabe G; Shiojima K; Nakayama T; Yoshida H; Kuwata S; Kinouchi T; Doba N
    Hypertens Res; 1999 Nov; 22(4):291-5. PubMed ID: 10580396
    [TBL] [Abstract][Full Text] [Related]  

  • 97. White coat effect and white coat hypertension: one and the same?
    Ramli A; Halmey N; Teng C
    Malays Fam Physician; 2008; 3(3):158-61. PubMed ID: 25606143
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Urinary albumin excretion in elderly patients with white coat hypertension.
    Di Mauro S; Spallina G; Scalia G; Insolia G; Borzí S; Distefano A; Torrisi G
    Arch Gerontol Geriatr; 1999; 28(1):23-9. PubMed ID: 18656100
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cardiovascular Alterations and Management of Patients With White Coat Hypertension: A Meta-Analysis.
    Xiang H; Xue Y; Wang J; Weng Y; Rong F; Peng Y; Ji K
    Front Pharmacol; 2020; 11():570101. PubMed ID: 33041810
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Nursing actions increases the control of hypertensive patients and reduces white-coat effect].
    Colósimo FC; da Silva SS; Toma Gde A; Pierin AM
    Rev Esc Enferm USP; 2012 Oct; 46 Spec No():10-5. PubMed ID: 23250252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.